This website is intended exclusively for healthcare professionals residing and/or working in Kuwait.
Prof. Abdulrahman A. Alshaikh, Professor Physician & Endocrinologist at KAU & DSFH, Chairman of Saudi Scientific Diabetes Society, Saudi Arabia, presents iGlarLixi safety and effectiveness in adults with T2D who fast during Ramadan in Gulf region (SoliRam study sub-analysis).
MAT-BH-2300251/V1/March2023
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.